JPRN-UMIN000002892已完成未知
Tocilizumab treatment of cyclophosphamide-resistant patients with ANCA-associated vasculitis - ToCRAV
Research Committee of multicentre clinical trials for intractable ANCA-associated vasculitis of the Ministry of Health, Labor and Welfare of Japan0 个研究点目标入组 5 人开始时间: 2009年12月14日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 5
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. severe infection (including tuberclosis and HIV). 2. Hepatitis B e antigen positive or Hepatitis C antibody positive. 3. Previous cyclophosphamide, (greater than 4 weeks of IV pulse cyclophosphamide regimen). 4. Previous cyclophosphamide, (greater than 2 weeks of an oral cyclophosphamide regimen). 5. WBC <3,500/microlitter. 6. platelet <100,000/microlitter. 7. lymphocytes<1,000/microlitter 8. Pregnancy or breast feeding 9. inadequate contraception
研究者
相似试验
招募中
2 期
Clinical trial of tocilizumab versus cyclophosphamide for microscopic polyangiitis and granulomatosis with polyangiitisMicroscopic polyangiitis (MPA) Granulomatosis with polyangiitis (GPA)JPRN-jRCT1091220325Masayoshi Harigai48
招募中
2 期
Clinical trial of tocilizumab versus cyclophosphamide for microscopic polyangiitis and granulomatosis with polyangiitisMicroscopic polyangiitis (MPA) Granulomatosis with polyangiitis (GPA)JPRN-UMIN000024574Tokyo women's medical university Institute of rheumatology48
尚未招募
2 期
Tocilizumab for the treatment of retroperitoneal fibrosisretroperitoneal fibrosisACTRN12618000922279Azienda Ospedaliero Universitaria di Parma18
已完成
不适用
Tocilizumab treatment with reducing and stopping methotrexate in patients with rheumatoid arthritis in stable low disease activity-stateRheumatoid arthritisJPRN-UMIN000021247agoya University Hospital53
进行中（未招募）
1 期
TOCIlizumab for difficult-to-treat RETroperitoneal fibrosis. TOCIRET Trial”idiopathic retroperitoneal fibrosisMedDRA version: 20.1Level: LLTClassification code 10021244Term: Idiopathic retroperitoneal fibrosisSystem Organ Class: 100000004856EUCTR2017-001429-41-ITAZIENDA OSPEDALIERO-UNIVERSITARIA DI PARMA18